Cutler Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-9,400
| Closed | -$95K | – | 1386 |
|
2022
Q4 | $95K | Buy |
9,400
+2,654
| +39% | +$26.8K | 0.01% | 626 |
|
2022
Q3 | $66K | Buy |
+6,746
| New | +$66K | ﹤0.01% | 803 |
|
2022
Q2 | – | Sell |
-2,200
| Closed | -$21K | – | 1844 |
|
2022
Q1 | $21K | Sell |
2,200
-3,191
| -59% | -$30.5K | ﹤0.01% | 1343 |
|
2021
Q4 | $77K | Buy |
5,391
+4,601
| +582% | +$65.7K | ﹤0.01% | 1023 |
|
2021
Q3 | $15K | Sell |
790
-2,810
| -78% | -$53.4K | ﹤0.01% | 1599 |
|
2021
Q2 | $79K | Buy |
3,600
+2,200
| +157% | +$48.3K | ﹤0.01% | 1070 |
|
2021
Q1 | $47K | Buy |
+1,400
| New | +$47K | ﹤0.01% | 1190 |
|